Скачать с ютуб Building Global Biotech Startups | IndieBio | SOSV - The Accelerator VC в хорошем качестве

Building Global Biotech Startups | IndieBio | SOSV - The Accelerator VC

A discussion between IndieBio, Entrepreneur First and BioFeyn on how to access resources and communities on both sides of the Atlantic. How do European biotech startups access resources in the US, and vice versa? What benefits does a startup receive by participating in an incubator/accelerator program? This conversation brings together the Entrepreneur First and IndieBio programs and introduces BioFeyn to discuss milestones reached while a part of both programs. JONNY EVERETT Programme Manager and Entrepreneur in Residence at Entrepreneur First. Jonny is an Entrepreneur in Residence at Entrepreneur First. He devotes his time to help the amazing talent that joins EF to build the game-changing companies of tomorrow in tech and deep tech. Previously, he co-founded The Chat Shop, bootstrapping the business to 100 employees over 7 years. Entrepreneur First is the world’s leading talent investor. We believe the best way for the most impactful & ambitious people to fulfill their potential is to build companies. We transform their lives by enabling them to become founders. We fund the most talented individuals before they have a team and before they have an idea, helping them to create the next generation of globally ambitious technology startups from scratch. Since 2011, over 2,000+ individuals went through our programmes, creating 350+ companies and raising over $500m of investment with a combined valuation of over $2 billion. Apply here before February 14th to get the chance to join our next cohort starting in April 2021 alongside the world’s most talented individuals. https://www.joinef.com TIMOTHY BOULEY CEO and co-founder of BioFeyn Timothy is the CEO and co-founder of BioFeyn Inc, a new company optimizing ocean nutrients to improve the health and nutrition of farmed fish, while decreasing environmental impact. He previously founded at led programs at World on climate change and health, One Health, and oceans. Trained as a medical doctor and environmental scientist, he has also worked at the US National Academy of Sciences, the World Health Organization, and the University of California, San Francisco. He holds degrees in biology, bioethics, geography, and medicine from Tufts, Harvard, Oxford, and Duke. BioFeyn adapts nanotechnologies based on human medicine to deliver nutrients and natural disease preventatives to fish. BioFeyn’s goal is to produce the most sustainable and nutrient-packed farmed fish on the market by optimizing existing ingredients that are already proven to be safe and sustainable. We add value for farmers, feed suppliers, and the environment. https://www.biofeyn.com JULIE WOLF Communications Director at IndieBio New York Julie Wolf is the Communications Director of IndieBio NY, where she promotes breakthrough biotech applications and the founders who develop them. Prior to joining IndieBio, Julie worked for the American Society for Microbiology and was part of the founding team at the synthetic biology start-up Brooklyn Bio Inc. She maintains a strong commitment to scientific education and teaches molecular biology at the New York community biolab, Genspace. She is passionate about making science accessible and relevant to everyone. IndieBio is the world’s leading biotech accelerator, funding scientists who work on the biggest problems on the planet. Twice a year, 15 companies gather for an intensive four-month program to learn the skills and build the networks needed to be successful. Each team receives $250,000 in seed funding, lab and co-working space, dedicated mentorship, and becomes part of a huge network of IndieBio alumni, investors, biotech entrepreneurs, investors, press, corporate partners, and more. https://indiebio.co ► Subscribe for more content from SOSV: https://bit.ly/2AXgcLk ► Learn the language of Venture Capital with VC Lingo at: https://goo.gl/vHB7kP ► More insights into top Venture Capital firms from the VCs that run them via 42 Questions: https://bit.ly/2lIfZYs